Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma

Medical Physics

Volumn 31, Issue 9, 2004, Pages 2449-2453

  Sarfaraz, Mehrdad ^a   Kennedy, Andrew S ^b   Lodge, Martin A ^c   Li, X Allen ^d   Wu, Xingen ^a   Yu, Cedric X ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b PLLC   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Hepatic cancers; Microspheres therapy; Radiation absorbed dose distribution; Yttrium 90

Indexed keywords

GRAPHIC METHODS; MICROSPHERES; PARTICLE BEAMS; PATIENT MONITORING; PATIENT TREATMENT; TUMORS; YTTRIUM;

ABSORBED DOSE DISTRIBUTION; DOSE-VOLUME HISTOGRAMS; HEPATIC CANCERS; HEPATOCELLULAR CARCINOMA; MONTE CARLO CALCULATION; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGES; THREEDIMENSIONAL (3-D); YTTRIUM-90;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

MICROSPHERE; MICROSPHERE Y 90; THERAPSPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; HUMAN; IMAGE PROCESSING; LIVER CELL CARCINOMA; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 4644341544     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1781332     Document Type: Article

References (21)

1. M. Sarfaraz, A. S. Kennedy, Z. J. Cao, G. D. Sackett, C. X. Yu, M. A. Lodge, R. Murthy, B. R. Line, and D. A. Van Echo, "Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors," Med. Phys. 30, 199-203 (2003).
2. J. Dancey, F. A. Shepard, K. Paul, K. W. Sniderman, S. Houle, J. Gabrys, A. Hendler, and J. E. Goin, "Treatment of nonresectable hepatocellular carcinoma with intrahepatic Y-90 microspheres," J. Nucl. Mater. 41, 1673-1681 (2000).
3. W. Lau, S. Ho, T. W. T. Leung, M. Chan, R. Ho, P. J. Johnson, and A. K. C. Li, "Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of yttrium-90 microspheres," Int. J. Radiat. Oncol., Biol., Phys. 40, 583-592 (1998).
4. J. Andrews, S. C. Walker, R. J. Ackerman, L. A. Cotton, W. D. Ensminger, and B. Shapiro, "Hepatic radioembolization with yttrium-90 containing glass microspheres: Preliminary results and clinical follow-up," J. Nucl. Mater. 35, 1637-1644 (1994).
5. B. Gray, J. E. Anderson, M. A. Burton, G. Van Hazel, J. Codde, C. Morgan, and P. Klemp, "Regression of liver metastases following treatment with yttrium-90 microspheres," Aust. N. Z. J. Surg. 62, 105-110 (1992).
6. S. Ho, W. Y. Lau, T. W. Leung, M. Chan, Y. K. Ngar, P. J. Johnson, and A. K. Li, "Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumors," Eur. J. Nucl. Med. 23, 947-952 (1996).
7. P. Roberson, R. K. Ten Haken, D. L. McShan, P. E. McKeever, and W. D. Ensminger, "Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy," J. Nucl. Med. 33, 735-738 (1992).
8. A. Campbell, I. H. Bailey, and M. A. Burton, "Tumor dosimetry in human liver following hepatic yttrium-90 microsphere therapy," Phys. Med. Biol. 46, 487-498 (2001).
9. R. Fox, P. F. B. Klemp, G. Egan, L. L. Mina, M. A. Burton, and B. N. Gray, "Dose distribution following selective internal radiation therapy," Int. J. Radiat. Oncol., Biol., Phys. 21, 463-467 (1991).
10. G. S. S. Sgouros, A. M. Ballangrud, K. S. Kolbert, J. B. Teitcher, K. S. Panageas, R. D. Finn, C. R. Divgi, S. M. Larson, and A. D. Zelenetz, "Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with I131-anti-B1 antibody: Assessment of tumor doseresponse," J. Nucl. Med. 44, 260-268 (2003).
11. K. S. S. G. Kolbert, A. M. Scott, J. E. Bronstein, R. A. Malane, J. Zhang, H. Kalaigian, S. McNamara, L. Schwartz, and S. M. Larson, "Implementation and evaluation of patient-specific three-dimensional internal dosimetry," J. Nucl. Med. 38, 301-308 (1997).
12. M. Sarfaraz, X. Wu, M. A. Lodge, and C. X. Yu, "Automatic CT-SPECT registration of livers treated with radioactive microspheres," Phys. Med. Biol. 49, N131-N137 (2004).
13. A. Bielajew and D. W O. Rogers, "The parameter reduced electron-step transport algorithm for electron Monte Carlo transport," Nucl. Instrum. Methods Phys. Res. B 18, 165-181 (1987).
14. W. Nelson, H. Hirayama, and D. W O. Rogers, "The EGS4 code system," Stanford, CA, 1985.
15. D. Rogers and A. F. Bielajew, "Monte Carlo techniques of electron and photon transport for radiation dosimetry," in The Dosimetry of Ionizalion Radiation, edited by B. E. B. K. R. Kase and F. H. Attix (Academic, New York, 1990), pp. 427-539.
16. C. Ma, P. Reckwerdt, M. Holmes, D. W. O. Rogers, and B. Geiser, DOSXYZ users manual, 1995, NRC.
17. W. Cross, H. Ing, and N. Freedman, "A short atlas of beta-ray spectra," Phys. Med. Biol. 28, 1251-1260 (1983).
18. J. M. Franquiz, and C. S. Kandagatla, "Technical note: Beta voxel S values for internal emitter dosimetry," Med. Phys. 30, 1030-1032 (2003).
19. W. E. Bolch et al, "MIRD Pamphlet No. 17: The dosimetry of nonuniform activity distributions-radionuclides S values at the voxel level," J. Nucl. Mater. 40, 11S-36S (1999).
20. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin, and M. Wesson, "Tolerance of normal tissue to therapeutic irradiation," Int. J. Radiat. Oncol., Biol., Phys. 21, 109-122 (1991).
21. L. Dawson, N. Daniel, J. M. Balter, C. J. McGinn, T. S. Lawrence, and R. K. Ten Haken, "Analysis of radiation-induced liver disease using the Lyman NTCP model," Int. J. Radiat. Oncol., Biol., Phys. 53, 810-821 (2002).